Depatuxizumab MMAE

Item number	Size	Datasheet	Manual	SDS	Delivery time	Price
BPS-82927-1	1 mg	-	-	-	3 - 8 business days*	1,573.00€
BPS-82927-2	5 mg	-	-	-	3 - 8 business days*	3,587.00€
BPS-82927-3	10 mg	-	-	-	3 - 8 business days*	5,485.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising an anti EGFR monoclonal... more

Close menu

Product information "Depatuxizumab MMAE"

Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising an anti EGFR monoclonal antibody (Depatuxizumab) and the cytotoxic agent Monomethyl auristatin E (MMAE). Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR1.

Keywords:	Anti-ERBB, EC=2.7.10.1, Anti-Proto-oncogene c-ErbB-1, Anti-Epidermal growth factor receptor, Anti-Receptor tyrosine-protein kinase erbB-1,
Supplier:	BPS Bioscience
Supplier-Nr:	82927

Properties

Application:	Cancer therapy target studies
Antibody Type:	Monoclonal
Conjugate:	No
Species reactivity:	human
MW:	~148 kD
Format:	Solution

Database Information

KEGG ID :	K04361 \| Matching products
UniProt ID :	P00533 \| Matching products
Gene ID :	GeneID 1956 \| Matching products

Handling & Safety

Storage:	-80°C (protect from light)
Shipping:	-80°C (International: -80°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

View product citations for antibody 82927 on CiteAb

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Depatuxizumab MMAE"

Write a review